Faisal Khurshid
Stock Analyst at Jefferies
(4.98)
# 47
Out of 4,512 analysts
239
Total ratings
68.3%
Success rate
74.1%
Average return
Main Sectors:
Stocks Rated by Faisal Khurshid
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintained: Buy | $175 → $160 | $110.11 | +45.31% | 3 | Jul 13, 2026 | |
| ONC BeOne Medicines AG | Upgraded: Buy | $333 → $380 | $306.56 | +23.96% | 3 | Jul 12, 2026 | |
| ABVX ABIVAX Société Anonyme | Upgraded: Buy | $90 → $158 | $134.91 | +17.12% | 4 | Jul 1, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Buy | $29 → $30 | $19.08 | +57.23% | 2 | Jun 30, 2026 | |
| VSTM Verastem | Maintained: Buy | $15 → $8 | $5.57 | +43.63% | 2 | Jun 23, 2026 | |
| PTCT PTC Therapeutics | Upgraded: Buy | $76 → $85 | $78.06 | +8.89% | 2 | May 27, 2026 | |
| SMMT Summit Therapeutics | Maintained: Hold | $17 | $15.47 | +9.89% | 3 | May 21, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $290 | $265.57 | +9.20% | 2 | May 6, 2026 | |
| SNDX Syndax Pharmaceuticals | Maintained: Buy | $40 → $37 | $24.13 | +53.34% | 2 | May 1, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $140 | $184.97 | -24.31% | 2 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $11.70 | +79.49% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $103 → $120 | $80.55 | +48.98% | 14 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $38.51 | +42.82% | 1 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $330 | $281.26 | +17.33% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $94 | $114.88 | -18.18% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $9.35 | +92.51% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $118 → $110 | $112.08 | -1.86% | 16 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 | $33.47 | -1.40% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $13.67 | +9.73% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $142 | $109.96 | +29.14% | 8 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $21 | $14.57 | +44.13% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $4 | $6.74 | -40.65% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $22.98 | -47.78% | 8 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $29 → $40 | $29.47 | +35.73% | 11 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 → $9 | $3.88 | +131.96% | 11 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.486 | - | 17 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.76 | - | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.06 | - | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.91 | - | 17 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.69 | - | 13 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $131.27 | - | 2 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $98.95 | - | 10 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $2 | $6.29 | -68.20% | 4 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.38 | +117.39% | 17 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $3.98 | -74.87% | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.09 | +83.49% | 14 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $75.50 | - | 1 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.58 | n/a | 7 | Nov 9, 2023 |
Insmed
Jul 13, 2026
Maintained: Buy
Price Target: $175 → $160
Current: $110.11
Upside: +45.31%
BeOne Medicines AG
Jul 12, 2026
Upgraded: Buy
Price Target: $333 → $380
Current: $306.56
Upside: +23.96%
ABIVAX Société Anonyme
Jul 1, 2026
Upgraded: Buy
Price Target: $90 → $158
Current: $134.91
Upside: +17.12%
Viridian Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $29 → $30
Current: $19.08
Upside: +57.23%
Verastem
Jun 23, 2026
Maintained: Buy
Price Target: $15 → $8
Current: $5.57
Upside: +43.63%
PTC Therapeutics
May 27, 2026
Upgraded: Buy
Price Target: $76 → $85
Current: $78.06
Upside: +8.89%
Summit Therapeutics
May 21, 2026
Maintained: Hold
Price Target: $17
Current: $15.47
Upside: +9.89%
Ascendis Pharma
May 6, 2026
Maintained: Buy
Price Target: $290
Current: $265.57
Upside: +9.20%
Syndax Pharmaceuticals
May 1, 2026
Maintained: Buy
Price Target: $40 → $37
Current: $24.13
Upside: +53.34%
Revolution Medicines
Apr 10, 2026
Maintained: Buy
Price Target: $140
Current: $184.97
Upside: -24.31%
Mar 30, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $11.70
Upside: +79.49%
Mar 25, 2026
Maintained: Buy
Price Target: $103 → $120
Current: $80.55
Upside: +48.98%
Mar 16, 2026
Initiated Coverage: Buy
Price Target: $55
Current: $38.51
Upside: +42.82%
Mar 15, 2026
Downgraded: Hold
Price Target: $330
Current: $281.26
Upside: +17.33%
Mar 15, 2026
Downgraded: Hold
Price Target: $94
Current: $114.88
Upside: -18.18%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $9.35
Upside: +92.51%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $118 → $110
Current: $112.08
Upside: -1.86%
Mar 15, 2026
Downgraded: Hold
Price Target: $33
Current: $33.47
Upside: -1.40%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $13.67
Upside: +9.73%
Dec 15, 2025
Maintained: Buy
Price Target: $142
Current: $109.96
Upside: +29.14%
Dec 15, 2025
Reiterated: Buy
Price Target: $20 → $21
Current: $14.57
Upside: +44.13%
Nov 7, 2025
Downgraded: Hold
Price Target: $5 → $4
Current: $6.74
Upside: -40.65%
Oct 23, 2025
Reiterated: Hold
Price Target: $12
Current: $22.98
Upside: -47.78%
Oct 22, 2025
Upgraded: Buy
Price Target: $29 → $40
Current: $29.47
Upside: +35.73%
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $7 → $9
Current: $3.88
Upside: +131.96%
Sep 30, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.486
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $16.76
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $5.06
Upside: -
Sep 29, 2025
Reiterated: Buy
Price Target: n/a
Current: $17.91
Upside: -
Sep 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $14.69
Upside: -
Sep 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $131.27
Upside: -
Sep 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $98.95
Upside: -
Aug 18, 2025
Maintained: Buy
Price Target: $4 → $2
Current: $6.29
Upside: -68.20%
Aug 12, 2025
Reiterated: Buy
Price Target: $3
Current: $1.38
Upside: +117.39%
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $3.98
Upside: -74.87%
Aug 7, 2025
Reiterated: Hold
Price Target: $2
Current: $1.09
Upside: +83.49%
Jul 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $75.50
Upside: -
Nov 9, 2023
Reiterated: Hold
Price Target: $2
Current: $1.58
Upside: n/a